Hypogonadism in hereditary hemochromatosis
One promising strategy involves modulation of activating transcription factor 6 (ATF6), a key mediator of adaptive UPR signaling
Kadego, kto chce mie wicej energii i czu si lepiej na co dzie dziaa detoksykacyjnie, poprawia funkcjonowanie organizmu i wspiera dobre samopoczucie
Disclosures: Deanna Oliver: Nothing to Disclose, Renee Pozza: Nothing to Disclose, Fatma Barakat: Nothing to Disclose, Nothing to Disclose, Julian Diaz-Moreno: Nothing to Disclose, Michael Tunkelrott: Nothing to Disclose, Victoria Aksakovska: Amsety: Employee, Jutta Kurz: Nothing to Disclose, Mustafa Behan: Amsety GmbH: Founder and Co-Owner, Emmanuel Gorospe: Nothing to Disclose, Tarek Hassanein: Nothing to Disclose 1385 NO INITIAL INCREASE IN CANCER RISK WITH GLUCAGON LIKE PEPTIDE-1 THERAPIES FOLLOWING LIVER TRANSPLANTATION Muhammad Saad Faisal 1 Abdulmalik Saleem 2 Ammad Chaudhary 2 Minahil Fatima 3 Muhammad Shahzil 4 Mohammed Abusuliman 2 Muhammad Salman Faisal 2 Syed-Mohammed Jafri 2 , 1 Henry Ford Hospital, Detroit, MI, 2 Henry Ford Health System, 3 King Edward Medical University, Lahore, Pakistan, 4 Weiss Memorial Hospital, Chicago, IL Background: Patients who undergo liver transplantation are at higher risk of complications from diabetes and obesity
Our ambition is to empower our customers to improve and extend their health span through testing, teaching, and transforming health, so they can prevent adverse chronic health conditions before they begin
